Clinical Trials Directory

Trials / Completed

CompletedNCT00708929

Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Age related macular degeneration (AMD) is a multifactorial disease with a strong genetic component. Most importantly a genetic polymorphism in the gene encoding for the complement factor H (CFH) has been recently identified which is highly associated with an increased risk of developing AMD. This Tyr402His polymorphism located on chromosome 1q31 has been implicated to play a role in the development of the disease. Given that it is known that impaired regulation of choroidal vascular tone is present in patients with AMD, the current study seeks to investigate whether the Tyr402His polymorphism is associated with altered choroidal autoregulation in healthy subjects. For this purpose a total of 100 healthy volunteers will be included in order to test the hypothesis that an impaired regulation of choroidal blood flow is present in subjects with homozygous Tyr402His variant.

Conditions

Interventions

TypeNameDescription
PROCEDURESquattingSquatting for 6 minutes

Timeline

Start date
2009-06-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2008-07-03
Last updated
2013-03-19

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00708929. Inclusion in this directory is not an endorsement.